头颈游离皮瓣重建中的多模式镇痛:系统综述
本系统综述纳入10项研究共1253例患者,比较多模式镇痛(MMA)与阿片类药物在头颈癌游离皮瓣重建术后的安全性和有效性。八项研究报告MMA组术后阿片类药物用量显著减少,主观疼痛评分多数研究显示显著改善,而手术结果、医疗并发症、不良反应及30天死亡率和再入院率无差异。
要点
- MMA可显著减少头颈游离皮瓣重建术后阿片类药物用量。
- MMA未增加手术并发症、不良反应或30天死亡/再入院风险。
- 加巴喷丁类药物是最常用的MMA干预措施(72.9%)。
核心结论
- 多模式镇痛可能对头颈癌游离皮瓣重建术后疼痛管理发挥重要作用。
研究设计与样本
- 系统综述,检索PubMed、Cochrane、Embase、Scopus和clinicaltrials.gov,纳入比较MMA与阿片类药物的研究。
- 共纳入10项研究,1253例患者(MMA组n=594,非MMA组n=659)。
主要发现
- 八项研究报告MMA组术后阿片类药物用量显著减少。
- 主观疼痛评分变异较大,但多数研究引用显著疼痛改善。
- 手术结果、医疗并发症、不良反应及30天死亡率和再入院率无差异。
关键数值与推荐
- MMA干预包括加巴喷丁类药物(72.9%)、NSAIDs(44.6%)、对乙酰氨基酚(44.3%)、皮质类固醇(25.1%)、氯胺酮(7.2%)和神经阻滞(3.4%)。
临床怎么用
- 考虑将多模式镇痛方案用于头颈癌游离皮瓣重建患者的围手术期疼痛管理,以减少阿片类药物用量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative pain after head and neck cancer surgery is commonly treated with opioids, which are associated with considerable side effects. The objective of this study is to analyze the safety and efficacy of using multimodal analgesia (MMA) for patients undergoing head and neck cancer surgery with free flap reconstruction. DATA SOURCES: A systematic search was conducted in PubMed, Cochrane, Embase, Scopus, and clinicaltrials.gov. REVIEW METHODS: All studies comparing patients receiving MMA (gabapentin, corticosteroids, local anesthetic, acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs]) vs patients receiving opioids for head and neck cancer surgery with free flap reconstruction were screened. The primary outcome was postoperative opioid usage. Secondary outcomes included length of stay, subjective pain scores, surgical/medical complications, adverse effects, and 30-day outcomes. RESULTS: A total of 10 studies representing 1253 patients (MMA, n = 594; non-MMA, n = 659) met inclusion criteria. Gabapentinoids were the most commonly used intervention (72.9%) followed by NSAIDs (44.6%), acetaminophen (44.3%), corticosteroids (25.1%), ketamine (7.2%), and nerve block (3.4%). Eight studies reported a significant decrease in postoperative opioid usage in the MMA groups. Subjective pain had wider variation, with most studies citing significant pain improvement. There were no differences in surgical outcomes, medical complications, adverse effects, or 30-day mortality and readmission rates. CONCLUSION: With the rise of the opioid epidemic, MMA may play an important role in the treatment of postoperative pain after head and neck cancer surgery. A growing body of literature demonstrates a variety of effective perioperative regimens.
引用
- Go BC, Go CC, Chorath K, et al. Multimodal Analgesia in Head and Neck Free Flap Reconstruction: A Systematic Review. Otolaryngol Head Neck Surg. 2021. PMID: 34372726. doi:10.1177/01945998211032910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。